Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BackToBasic infliximab trial in chronic low back pain with Modic type 1 changes
2017-004861-29Phase 3Completed
- Sponsor
- FOU, Nevroklinikken, Oslo University Hospital -Ullevål
- Start
- Apr 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of infliximab in chronic low back pain (CLBP), sponsored by FOU, Nevroklinikken, Oslo University Hospital -Ullevål. Primary endpoint: Oswestry Disability Index (ODI) 2.0 responder status. Started Apr 2018; status: completed.
02
Drugs
infliximab
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2017-004861-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004861-29.